NO303872B1 - Angiotensin II-antagoniserende imidazolderivater og farmasöytiske preparater inneholdende disse - Google Patents

Angiotensin II-antagoniserende imidazolderivater og farmasöytiske preparater inneholdende disse

Info

Publication number
NO303872B1
NO303872B1 NO931980A NO931980A NO303872B1 NO 303872 B1 NO303872 B1 NO 303872B1 NO 931980 A NO931980 A NO 931980A NO 931980 A NO931980 A NO 931980A NO 303872 B1 NO303872 B1 NO 303872B1
Authority
NO
Norway
Prior art keywords
antagonizing
angiotensin
pharmaceutical preparations
preparations containing
imidazole derivatives
Prior art date
Application number
NO931980A
Other languages
English (en)
Other versions
NO931980D0 (no
NO931980L (no
Inventor
Hiroaki Yanagisawa
Yasuo Shimoji
Yoshiya Amemiya
Takuro Kanazaki
Hiroyuki Koike
Toshio Sada
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO931980D0 publication Critical patent/NO931980D0/no
Publication of NO931980L publication Critical patent/NO931980L/no
Publication of NO303872B1 publication Critical patent/NO303872B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO931980A 1992-06-02 1993-06-01 Angiotensin II-antagoniserende imidazolderivater og farmasöytiske preparater inneholdende disse NO303872B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14116092 1992-06-02

Publications (3)

Publication Number Publication Date
NO931980D0 NO931980D0 (no) 1993-06-01
NO931980L NO931980L (no) 1993-12-03
NO303872B1 true NO303872B1 (no) 1998-09-14

Family

ID=15285532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931980A NO303872B1 (no) 1992-06-02 1993-06-01 Angiotensin II-antagoniserende imidazolderivater og farmasöytiske preparater inneholdende disse

Country Status (22)

Country Link
EP (1) EP0573218B1 (no)
JP (1) JP3461863B2 (no)
KR (1) KR100300473B1 (no)
CN (1) CN1051766C (no)
AT (1) ATE199548T1 (no)
AU (1) AU661153B2 (no)
CA (1) CA2097444C (no)
CZ (1) CZ287764B6 (no)
DE (1) DE69329982T2 (no)
DK (1) DK0573218T3 (no)
ES (1) ES2155827T3 (no)
FI (1) FI112476B (no)
GR (1) GR3035624T3 (no)
HK (1) HK1011983A1 (no)
HU (1) HUT64329A (no)
IL (1) IL105825A (no)
NO (1) NO303872B1 (no)
NZ (1) NZ247750A (no)
PT (1) PT573218E (no)
RU (1) RU2086541C1 (no)
TW (1) TW228521B (no)
ZA (1) ZA933824B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
EP1110551B1 (en) * 1994-03-16 2004-05-12 Sankyo Company Limited Ocular tension lowering agent
KR100428725B1 (ko) * 1996-03-30 2004-07-07 주식회사 현대시스콤 디지탈이동통신교환기녹음안내장치의2단계자체루프백시험장치및방법
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
CN1197866C (zh) * 2003-03-21 2005-04-20 上海医药工业研究院 4，6－二氢呋喃并[3,4－d]咪唑－6－酮衍生物及其盐和制备方法
ES2535291T3 (es) * 2003-04-15 2015-05-08 Daiichi Sankyo Company, Limited Medoxomilo de olmesartán para prevención o tratamiento de enfermedades oculares angiogénicas
WO2005077941A2 (en) 2004-02-11 2005-08-25 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
CN101024643A (zh) * 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑－5－羧酸类衍生物、制备方法及其应用
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
JP5685082B2 (ja) * 2007-08-08 2015-03-18 レツク・フアーマシユーテイカルズ・デー・デー オルメサルタンメドキソミルの調製または精製の方法
CN101481374B (zh) * 2008-01-09 2013-01-09 浙江华海药业股份有限公司 1-三苯甲基-5-(1，1｀-联苯基-2基)-1h-四唑类化合物脱去三苯甲基的方法
CN103319461A (zh) * 2013-07-02 2013-09-25 临海天宇药业有限公司 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法
CN104262332A (zh) * 2014-09-16 2015-01-07 上海信谊百路达药业有限公司 一种奥美沙坦酯的制备方法
CN104356069B (zh) * 2014-11-18 2016-09-14 黄冈鲁班药业有限公司 奥美沙坦酯中间体4-(1-羟基-1-甲基乙基)-2-丙基咪唑-5-羧酸乙酯的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
KR0163595B1 (ko) * 1989-06-30 1998-12-01 미리암디, 메코너헤이 치환된 이미다졸
IL98319A (en) * 1990-07-05 1997-04-15 Roussel Uclaf Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them
FI112942B3 (fi) * 1991-02-21 2012-03-13 Daiichi Sankyo Co Ltd Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi
EP0505098A1 (en) * 1991-03-19 1992-09-23 Merck & Co. Inc. Imidazole derivatives bearing acidic functional groups as angiotensin II antagonists

Also Published As

Publication number Publication date
AU3988093A (en) 1993-12-09
KR100300473B1 (ko) 2002-01-09
EP0573218A3 (en) 1994-06-01
DE69329982T2 (de) 2001-09-27
ZA933824B (en) 1993-12-27
GR3035624T3 (en) 2001-06-29
NO931980D0 (no) 1993-06-01
AU661153B2 (en) 1995-07-13
CN1085896A (zh) 1994-04-27
PT573218E (pt) 2001-06-29
IL105825A0 (en) 1993-09-22
HK1011983A1 (en) 1999-07-23
DE69329982D1 (de) 2001-04-12
HU9301600D0 (en) 1993-09-28
EP0573218B1 (en) 2001-03-07
FI932492A0 (fi) 1993-06-01
CA2097444C (en) 2005-03-29
NZ247750A (en) 1995-05-26
RU2086541C1 (ru) 1997-08-10
CN1051766C (zh) 2000-04-26
ATE199548T1 (de) 2001-03-15
TW228521B (no) 1994-08-21
JP3461863B2 (ja) 2003-10-27
EP0573218A2 (en) 1993-12-08
FI112476B (fi) 2003-12-15
NO931980L (no) 1993-12-03
DK0573218T3 (da) 2001-06-18
ES2155827T3 (es) 2001-06-01
CZ105093A3 (en) 1993-12-15
KR940000455A (ko) 1994-01-03
IL105825A (en) 1998-01-04
JPH0649036A (ja) 1994-02-22
CZ287764B6 (en) 2001-01-17
HUT64329A (en) 1993-12-28
FI932492A (fi) 1993-12-03
CA2097444A1 (en) 1993-12-03

Similar Documents

Publication Publication Date Title
NO303872B1 (no) Angiotensin II-antagoniserende imidazolderivater og farmasöytiske preparater inneholdende disse
NO180447C (no) Imidazol-, triazol- og tetrazolderivater, farmasöytiske preparater inneholdende disse, og anvendelse av forbindelsene for fremstilling av medikamenter
MY107756A (en) Piperazine derivatives.
NO174508C (no)
AU3401193A (en) Imidazole derivatives with a biphenylsulfonylurea or biphenylsulfonylurethane side chain, process for their preparation and their use
ATE196141T1 (de) Heterocyclisch substituierte phenyl-cyclohexan- carbonsäurederivate als angiotensin ii antagonisten
HU9600834D0 (en) Quinazoline derivatives
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
GR3035526T3 (en) Retroviral protease inhibitors.
EP1473294A3 (en) Substituted 1,3-oxathiolanes with antiviral properties
HUT65632A (en) Process for producing imidazole- and pyridine derivatives of biphenyl compounds and pharmaceutical preparations containing them
JPS6434979A (en) Pyrrolidine derivative and antiallergic composition
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
AU2323095A (en) Lactam derivatives useful for pharmaceutical purposes
AU6948091A (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
HU9201033D0 (en) Tiazolidinone- and oxazolidinone derivatives, process for their production, and for the production of medical preparations containing them as active agents
AU1810988A (en) Novel n-(4-piperidinyl)bicyclic condensed 2-imidazolamine derivatives
FI972510A (fi) Tiatsolidinoniyhdisteet ja niitä vaikuttavana aineena sisältävä valmiste rasitusrintakivun hoitoon tai ennaltaehkäisyyn
ES8704940A1 (es) Procedimiento de preparacion de nuevos derivados alquilamino-furanonas y de sales y diastereoisomeros farmaceuticamente aceptables de los mismos.
FI894125A (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
NZ271766A (en) 4-[2-(2-amino-4-oxo-4,5,7,8-tetrahydro-3h-pyrimido[5,4-6]-[1,4]heter ocycl-6-yl)-hydrocarbyl]-2,5-heterocycloylamino-l-glutamic acid)diethyl ester derivatives; intermediates
DE68918240T2 (de) 1,4-Dihydropyridin-Derivate.
MX9705648A (es) Empleo dermatologico de derivados de vitamina d.
TH14151EX (th) อนุพันธ์ต่าง ๆ ของอิมิดาโซลที่เป็นตัวต่อต้านฤทธิ์แอนจิโอเทนซิน ii, การเตรียมสารเหล่านี้และการใช้สารเหล่านี้บำบัดโรค

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees